LaGray Chemical Company of Nsawam and Anuh Pharma of Mumbai, India, have signed a two-year collaborative agreement for the manufacture of certain active pharmaceutical ingredients (APIs) in Ghana.
In the agreement which was signed at Nsawam, Anuh Pharma will transfer to LaGray technology for the manufacture of active pharmaceutical ingredients used in making essential anti-infective drugs.
The collaboration will enable LaGray to quickly manufacture anti-infectives for treating respiratory tract infections and opportunistic infections in HIV/AIDS patients.
“The acquisition of Anuh Pharma's technology goes a long way in enhancing our expertise and will help us to accelerate our mission to help to make Ghana and West Africa self-sufficient in drug manufacturing,” Dr Paul Lartey, President and Chief Executive Officer of LaGray said.
“We could not have asked for a better partner than Anuh Pharma, a company with decades of success in active pharmaceutical ingredient manufacturing and a genuine interest in helping us to achieve our goals,” he stated.
“We are very pleased to share our experience and expertise with a dynamic company like LaGray. It is gratifying to be associated with a company that is making history in drug manufacturing in Africa,” Mr Bipin Shah, the Managing Director of Anuh Pharma said.
LaGray Chemical Company is the first manufacturer of APIs in West Africa. The company's state-of-the-art facility is located at Nsawam, opposite the old GIHOC Cannery.
It is the first fully integrated pharmaceutical manufacturing plant in West Africa, with technology for the manufacture of both APIs and finished dosage forms.
Anuh Pharma is a 75-year-old Indian pharmaceutical company, with expertise in the manufacture of APIs. The range of services it offers includes technology transfer and consulting.